ArticleBioMed research international2020

Levosimendan Protects against Doxorubicin-Induced Cardiotoxicity by Regulating the PTEN/Akt Pathway.

Ling-Li Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.